Strengthening the National HIV Response


The Newlands Clinic (NC) is a national Centre of Excellence for the comprehensive care of HIV patients with complex and advanced diseases. Through its training centre and research capacities it informs and strengthens Zimbabwe’s national HIV response. Managed by the Swiss Ruedi Lüthy Foundation, Switzerland’s support to the Newlands Clinic contributes to Switzerland’s visibility and excellent reputation in the country. 

Región/País Tema Período Presupuesto
Zimbabwe
Salud
Educación
nothemedefined
Enfermedades de transmisión sexual inclusive el VIH/sida
Salud y derechos reproductivos
Education facilities and training
Educación sanitaria
15.06.2023 - 31.12.2028
CHF  3’815’000
Contexto Zimbabwe remains amongst the countries with the highest HIV prevalence rate worldwide for the age group of 15 to 49 years (11.6% in 2021). The country struggles to address the crisis, with inadequate public resources to provide quality services to the poor, and a shortage of health workers to deliver quality care and treatment. Thanks to Swiss support, over the past 20 years the Newlands Clinics has evolved into a centre of excellence for the comprehensive care of AIDS patients in Zimbabwe. Financially, the clinic remains heavily dependent on Swiss privat and public donations, and the NC’s costly treatment model limits its potential for replicability and scale up. Stepping up private sector engagement and accessing in-country funds will become essential for NC to ensure the viability of its operations. 
Objetivos To improve the quality of life of people living with HIV/AIDS and reduce morbidity, mortality, and transmission of HIV in Zimbabwe.
Grupos destinarios
  • Adult women, men, adolescents and children affected by HIV/AIDS
  • Doctors and nurses
  • Public and private clinics and hospitals
Efectos a medio plazo
  • Increased capacity built for OI/ART1 service delivery and task sharing through training, clinical attachment, mentorship, and rolling out components of the NC model of best practice
  • Increased survival and reduced mortality of 9,000 patients receiving treatment and care at NC
  • Influencing national and international policies and guidelines for the comprehensive management of people living with HIV and Aids through evidence-based research findings
Resultados

Resultados previstos:  

  • 9000 OI/ART patients in care by 2028
  • 10 provinces supported with training and mentorship
  • 5331 HCWs trained in Advanced HIV Management by 2028
  • 9200 HCWs trained by 2028 in HIV related short courses and mentorship
  • 850 girls immunised for HPV per year
  • 3200 women screened for cervical cancer per year by 2028
  • 1000 women receiving access to modern methods of family planning services
  • Viability of operations strenghtened through diversification of partners/donors


Resultados de las fases anteriores:  

  • 4076 Health Care Workers have been trained between 2020-2023 on HIV Management (advanced and basic courses)
  • One Continued Medical Education meeting held at a provincial Hospital for the local Health Care Workers in 2022
  • 7720 patients in care at the NC (2022), following a steady increase since 2016 (5776), with a very low mortality rate of 1% (70 patients)
  • The NC’s Mental and Social Health Department provided counselling to 1050 referred patients
  • 2286 women were screened for cervical cancer in 2022
  • The enrolment of patients with complex diseases and third-line patients significantly increased the cost of comprehensive care and will likely further increase the mortality and morbidity rates


Dirección / Officina Federal responsable COSUDE
Crédito Cooperación al desarrollo
Contrapartes del proyecto Contraparte del contrato
Sector privado
Organización suiza sin fines de lucro
  • Otra organización suiza sin fines lucrativos
  • Sector privado extranjero Sur/Este
  • Sector privado suizo
  • Ruedi Lüthy Foundation


Coordinación con otros proyectos y actores SDC supported Programmes: Zvandiri Programme, O3+, Future Life Now Others: Global Fund to fight AIDS, TB and Malaria, Health Resilience Fund
Presupuesto Fase en curso Presupuesto suizo CHF    3’815’000 Presupuesto actual suizo ya emitido CHF    764’575 Presupuesto inclusive contrapartes del proyecto CHF    34’800’000 Total del proyecto desde la primera fase Presupuesto suizo CHF   0
Fases del proyecto Fase 1 15.06.2023 - 31.12.2028   (Fase en curso)